AI is a viable alternative to high throughput screening: a 318-target studyJon M. Sorenson, Izhar Wallach, Denzil Bernard et al.|Scientific Reports|2024Cited by 121
Discovery of a novel SHIP1 agonist that promotes degradation of lipid-laden phagocytic cargo by microgliaChiara Pedicone, William G. Kerr, Stewart N. Loh et al.|iScience|2022Cited by 28
Author Correction: AI is a viable alternative to high throughput screening: a 318-target studyJon M. Sorenson, Izhar Wallach, Denzil Bernard et al.|Scientific Reports|2024Cited by 2